Navigation Links
NIAID expands capability for influenza research and surveillance

nia. They also will maintain a high-throughput laboratory network capable of providing real-time information about circulating influenza virus strains and antiviral drug resistance—information that will be most critical during the early stages of an influenza pandemic.

University of Minnesota, Minneapolis (principal investigator—Dr. Marguerite Pappaiaonou) These researchers will conduct international and domestic animal flu surveillance covering all major domestic flight paths of migratory birds. This center also will carry out a human influenza surveillance study in Thailand and will monitor U.S. agricultural workers who work with swine.

Emory University, Atlanta (principal investigator—Dr. Richard Compans) This center will conduct studies to determine how influenza viruses adapt to new hosts and are transmitted between different hosts, and analyze human immune responses to influenza vaccination and infection. The researchers will examine how human genes might be silenced to decrease or eliminate flu infections; identify new targets for antiviral medicines; and evaluate flu transmission between patients and physicians in the hospital emergency room setting. Emory will also offer a training program for postdoctoral fellows and veterinarians interested in influenza and other research performed in a biosafety level 3 laboratory.

Mount Sinai School of Medicine, New York City (principal investigator—Dr. Adolfo Garcia-Sastre) These researchers will conduct molecular studies to identify influenza virus genes associated with the development of disease, the adaptability of flu viruses in birds and mammals, and the transmission of flu viruses between different hosts.

University of Rochester, Rochester, NY (principal investigator—Dr. John Treanor) Dr. Treanor and his colleagues will establish a human surveillance system that will monitor selected communities in New York for seasonal flu virus infections, and will study the effecti
'"/>

Source:NIH/National Institute of Allergy and Infectious Diseases


Page: 1 2 3 4

Related biology news :

1. NIAID Initiates Trial of Experimental Avian Flu Vaccine
2. NIAID begins clinical trial of West Nile virus vaccine
3. New NIAID grants strengthen national biodefense and emerging infectious diseases research network
4. NIAID researchers show how promising TB drug works
5. NIAID DNA vaccine for H5N1 avian influenza enters human trial
6. International HapMap consortium expands mapping effort
7. Gene expands malarias invasion options
8. MWG Biotech expands siMAX?siRNA portfolio with new scales, lengths and design tools
9. NHGRI expands effort to revolutionize sequencing technologies
10. New book expands biological classifications to account for alien life
11. New study expands understanding of the role of RNA editing in gene control

Post Your Comments:
(Date:11/23/2009)...al in unprecedented detail how the ribosome intera...and guide them toward their destination in biologi...xible fitting (MDFF) to examine the interaction of...s. , The first study, in Proceedings of the Na... signaling between the ribosome and an elongation ...
(Date:11/23/2009)... , , , , , , , ...Andrew Marshall, from the Environment Department a...of Kinyongia magomberae and his wider work in Ta...nformation. , , , , , ... , , , , , A new species of chameleon ...
(Date:11/23/2009)...onmental irritants such as air pollution and cigar...ished today in the American Journal of Respirator...study, from Imperial College London and the Univer...the lungs that can trigger coughing when a person ...y suggest that their findings may ultimately lead ...
Breaking Biology News(10 mins):Computational microscope peers into the working ribosome 2Computational microscope peers into the working ribosome 3New chameleon species discovered in East Africa 2New chameleon species discovered in East Africa 3Research reveals exactly how coughing is triggered by environmental irritants 2DURECT Announces License of ADHD Drug Candidate in Selected Asian and South Pacific Countries to Orient Pharma 54723 1DURECT Announces License of ADHD Drug Candidate in Selected Asian and South Pacific Countries to Orient Pharma 54723 2DURECT Announces License of ADHD Drug Candidate in Selected Asian and South Pacific Countries to Orient Pharma 54723 3DURECT Announces License of ADHD Drug Candidate in Selected Asian and South Pacific Countries to Orient Pharma 54723 4SailPoint Expands European Presence Through Partnerships and Customer Wins 54720 1SailPoint Expands European Presence Through Partnerships and Customer Wins 54720 2SailPoint Expands European Presence Through Partnerships and Customer Wins 54720 3SailPoint Expands European Presence Through Partnerships and Customer Wins 54720 4Transcept Announces Plans to Reduce Expenses by Decreasing Staff Following Recent Completion of Purdue U S License and Collaboration Agreement 54716 1Transcept Announces Plans to Reduce Expenses by Decreasing Staff Following Recent Completion of Purdue U S License and Collaboration Agreement 54716 2Transcept Announces Plans to Reduce Expenses by Decreasing Staff Following Recent Completion of Purdue U S License and Collaboration Agreement 54716 3Transcept Announces Plans to Reduce Expenses by Decreasing Staff Following Recent Completion of Purdue U S License and Collaboration Agreement 54716 4Transcept Announces Plans to Reduce Expenses by Decreasing Staff Following Recent Completion of Purdue U S License and Collaboration Agreement 54716 5
... chasing younger women contributes to human,longev...new findings by,researchers at Stanford and the Un...ary theory says that individuals should die of old...enerally by age 55 in humans,according to demograp...gical sciences at Stanford. But the fatherhood of ...
...2, 2007 - UC Irvines Henry Samueli School of Engin... Lifesciences Corporation to establish a center fo...ation of cardiovascular devices. , The Edwards Li...nology will promote interaction and collaboration ...orporating both undergraduate and graduate program...
...007 A double amputee whose trailblazing work in t...e development of new prosthetic innovations that m... the 13th annual Heinz Award for Technology, the E...l achievement prizes in the world. , Dr. Hugh H...e of Technologys Media Lab whose advances in prost...
Other Biology News:Men shed light on the mystery of human longevity, study finds 2Men shed light on the mystery of human longevity, study finds 3Men shed light on the mystery of human longevity, study finds 4UCI receives $5M from Edwards Lifesciences 2Herr receives Heinz Award for Technology, the Economy and Employment 2Herr receives Heinz Award for Technology, the Economy and Employment 3Herr receives Heinz Award for Technology, the Economy and Employment 4
(Date:11/19/2009)...and WALTHAM, Mass., Nov. 19 Arling... find that the leading driver of antibiotic select...ctrum activity against gram-positive and gram-nega...at can cause nosocomial pneumonia, surveyed Europe...agents that provide appropriate coverage against c...
(Date:11/19/2009)... /PRNewswire/ - Aegera Therapeutics Inc. announced...ized Phase 2B study of AEG35156, a targeted antise...ple oncology indications. ,, The study, entitle...-Linked Inhibitor of Apoptosis (XIAP) Antisense AE...ine and Idarubicin in AML Following Failure of a S...
(Date:11/19/2009)...rld,s Top Gene Synthesis Companies Form Internatio... Best Practices in Risk Reduction ,Five Member C...nthesis Capacity , (PRWEB...eading gene synthesis companies today announced ag...otocol to promote biosecurity in the gene synthesi...
(Date:11/19/2009)...ustria, November 19 AFFiRiS AG wil...duct candidate at an unexpectedly early,stage of d...to enter into,Phase II clinical trial early in 201...s the completion of two Phase I trials with the ca... decision on the first interim,analysis of the sec...
Breaking Biology Technology:Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 2Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 3Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) 2World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 2World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 3World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 4AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 3
...m for Improving QPCR , , Strata...chines with , the Mx4000 multiplex quanti...rs better performance and functionality at a more ...QPCR) allows researchers to quickly and easily,q..., mutational analysis,disease state, and gene d...
...otal RNA from as few as 1 cell , Karen Dolte...total RNA microprep kit provides a,convenient me... cells. For,the purification, RNA is bound to a ...anic extraction and alcohol precipitation. The res...NA contamination and is suitable for,subsequent ...
...tein function more efficiently with standardized c...David T. Wong ,Kelly Wynne Vilma Nioko ,Leona... Marsh ,Stratagene , Spencer Stevens Chris Ha... now offers sequence-validated and expression-test...r. These clones eliminate the time spent,cloning...
Other Biology Technology:Mx4000 Multiplex Quantitative PCR System*,PPP 2Mx4000 Multiplex Quantitative PCR System*,PPP 3Mx4000 Multiplex Quantitative PCR System*,PPP 4Fast Isolation of Total RNA from Small Numbers of Cells 2Fast Isolation of Total RNA from Small Numbers of Cells 3Fast Isolation of Total RNA from Small Numbers of Cells 4Fast Isolation of Total RNA from Small Numbers of Cells 5Fast Isolation of Total RNA from Small Numbers of Cells 6Sequence-Validated and Expression-Tested Human cDNA in a Dual Expression,Vector 2Sequence-Validated and Expression-Tested Human cDNA in a Dual Expression,Vector 3Sequence-Validated and Expression-Tested Human cDNA in a Dual Expression,Vector 4Sequence-Validated and Expression-Tested Human cDNA in a Dual Expression,Vector 5Sequence-Validated and Expression-Tested Human cDNA in a Dual Expression,Vector 6
...client/server version of Freezerworks Unlimited in... workflow in high-volume labs and facilitates the ... need to share sample information. Network C...z, PPC 601); 13 in monitor with 256 colors; OS 8.6...
Rabbit Anti-Human PAC1 Antibody, Unconjugated from ABR-Affinity BioReagents
Microplate Rack for Standard Plates from Thermo Scientific
Serum aldolase Colorimetric Assay Kit, Stat-Pack from Caldon Biotech, Inc.
Biology Products: